Advance in therapy of acute Rhinitis - Comparison of efficacy and safety of Xylometazoline in combination Xylometazoline-Dexpanthenol in patients with acute Rhinitis;Fortschritt in der therapie der akuten Rhinitis: Vergleich der wirksamkeit und unbedenklichkeit von Xylometazolin mit der kombination von Xylometazolin-Dexpanthenol bei patienten mit akuter Rhinitis

Laryngo- Rhino- Otologie

Volumn 82, Issue 4, 2003, Pages 266-271

  Kehrl, Wolfgang ^a,d   Sonnemann, U ^b   Dethlefsen, U ^c  

^a Marienkrankenhaus   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c MKL Inst F Klin Forschung GmbH   (Germany)

^d Marienkrankenhaus GmbH   (Germany)

Author keywords

Acute Rhinitis; Dexpanthenol; Xylometazoline

Indexed keywords

DEXPANTHENOL; NASIC; XYLOMETAZOLINE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; ERYTHEMA; FEMALE; HUMAN; HYPERPLASIA; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NOSE DISEASE; NOSE MUCOSA; NOSE OBSTRUCTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REBOUND; RHINITIS; RHINORRHEA; SIDE EFFECT; TREATMENT OUTCOME; WOUND HEALING;

ACUTE DISEASE; ADMINISTRATION, INTRANASAL; ADULT; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; NASAL DECONGESTANTS; NASAL OBSTRUCTION; PANTOTHENIC ACID; RHINITIS; TREATMENT OUTCOME;

EID: 0037599343     PISSN: 09358943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38941     Document Type: Article

References (12)

1. Kehrl W, Sonnemann U. Dexpanthenol-Nasenspray als wirksames Therapieprinzip zur Behandlung der Rhinitis sicca anterior. Laryngo-Rhino-Otol 1998; 77: 506-512
2. Wei LJ, Lachin JM. Two-sample asymptotically distribution-free tests for incomplete multivariate observations. J Amer Statist Assoc 1984; 79: 653-661
3. Chapnik JS, Noyek AM. Medical Therapy in Rhinology. Otolaryng Clin North America 1984; 4: 685-695
4. Empey DW, Medder KT. Nasal Decongestants. Drugs 1981; 21: 438-443
5. Hamilton LH. Effect of xylometazoline nasal spray on nasal conductance in subjects with coryza. J Otolaryngol 1981; 10: 109-116
6. Petruson B. Treatment with xylometazoline (Otrivin7) nosedrops over a six-week period. Rhinology 1981; 19: 167-172
7. Chaplin S. Adverse Reactions to Sympathomimetics in Cold Remedies. Adverse Drug Reaction Bull 1984; 107: 396-399
8. Hauptmann S, Schäfer H, Fritz A, Hauptmann P. Untersuchung der wachstumsbeeinflussenden Wirkung von Wundsalben an der Zellkultur. Hautarzt 1992; 43: 432-435
9. Hosemann W, Göde U, Länger F, Wigand ME. Experimentelle Untersuchungen zur Wundheilung in den Nasennebenhöhlen. HNO 1991; 39: 48-54
10. Kehrl W, Sonnemann U. Verbesserung der Wundheilung nach Nasenoperationen durch kombinierte Anwendung von Xylometazolin und Dexpanthenol. Laryngo-Rhino-Otol 2000; 79: 151-154
11. Szorady I. Die klinische Bedeutung der Pantothensäure unter besonderer Berücksichtigung der Kinderheilkunde. Studia Medica Szegedinensia Tomus, Szeged 1967; 5: 41, 33, 52, 68, 74, 75, 80
12. Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ 1996; 12: 71-72